Nursing Facilities & Kickbacks – Is the DOJ Shifting Away from Pharma?
Kaitlin Fallon Wildoner, Esq., Senior Staff Writer, Life Science Compliance Update
DOJ may have a new focus for Anti-Kickback Statute violations: care facilities and their owners. This year alone, at least two high-profile cases have emerged where a care facility wound up in high-profile enforcement actions involving anti-kickback violations. This article examines the cases and explores why life science compliance professionals should pay attention to them.